AI Article Synopsis
- * A case study presented a patient with both COVID-19 and asthma, highlighting a prolonged recovery period of 41 days before they tested negative for the virus.
- * The findings emphasize the need for careful monitoring and treatment adjustments, suggesting a potential link between glucocorticoid therapy and faster virus clearance.
Article Abstract
Background: Coronavirus disease 2019 (COVID-19) is a public health emergency of international concern. The global population lacks immunity to COVID-19 and is generally susceptible. Underlying conditions, especially chronic respiratory diseases, may affect progression, treatment and prognosis of COVID-19.
Case Summary: We report a patient with confirmed COVID-19 combined with asthma. It took 41 d from disease onset to discharge to obtain two negative tests for this coronavirus.
Conclusion: This case indicates the dynamic clinical characteristics, laboratory and computed tomography findings and adjustment of treatment, and the possible relationship between glucocorticoid therapy and coronavirus clearance.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441254 | PMC |
| http://dx.doi.org/10.12998/wjcc.v8.i15.3355 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!